ISRCTN47755726
Completed
Not Applicable
A randomised, controlled, assessor-blind, clinical trial to demonstrate superiority of Hedrin 4% dimeticone lotion compared with Derbac-M 0.5% malathion aqueous liquid in the treatment of head lice
Thornton & Ross Ltd (UK)0 sites73 target enrollmentDecember 27, 2006
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Thornton & Ross Ltd (UK)
- Enrollment
- 73
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Participants aged six months and over with no upper age limit
- •2\. Participants who, upon examination, are confirmed to have live head lice
- •3\. Participants who give written informed consent, or if the participant is under 16 years of age whose parent/guardian gives written informed consent to participate in the study
- •4\. Participants who will be available for home visits by Medical Entomology Centre (MEC) study team members over the 14 days following first treatment
Exclusion Criteria
- •1\. Participants with a known sensitivity to any of the ingredients in Hedrin 4% lotion or Derbac\-M liquid
- •2\. Participants with a secondary bacterial infection of the scalp (e.g. impetigo) or who have a long\-term scalp condition (e.g. psoriasis of the scalp)
- •3\. Participants who have been treated with other head lice products within the previous two weeks
- •4\. Participants who have bleached hair, or hair that has been colour treated or permanently waved within the previous four weeks (wash in/wash out colours are acceptable)
- •5\. Participants who have been treated with the antibiotics Co\-Trimoxazole, Septrin or Trimethoprim within the previous four weeks, or who are currently taking such a course
- •6\. Pregnant or nursing mothers
- •7\. Participants who have participated in another clinical study within one month before entry to this study
- •8\. Participants who have already participated in this clinical study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
A randomised, controlled, assessor-blind, clinical trial to demonstrate superiority of Hedrin 4% dimeticone lotion compared with Derbac-M 0.5% malathion aqueous liquid in the treatment of head lice - Is Hedrin 4% more effective than Derbac-M for the treatment of head lice?EUCTR2006-004136-73-GBThornton & Ross Limited
Active, not recruiting
Not Applicable
A randomised, controlled, assessor-blind, clinical trial to demonstrate superiority of Hedrin® Once liquid gel compared with Lyclear 1% permethrin crème rinse in the treatment of head lice - Hedrin Once versus Lyclear against head liceHead louse infestation (pediculosis capitis)MedDRA version: 13.1Level: LLTClassification code 10034214Term: Pediculus capitis (head louse)System Organ Class: 10021881 - Infections and infestationsEUCTR2011-000257-23-GBThornton & Ross Ltd84
Active, not recruiting
Not Applicable
A randomised, controlled, assessor-blind, clinical trial to compare Liceko ® with NIX/Lyclear 1% permethrin crème rinse in the treatment of head lice. - Is Liceko ® more effective than Lyclear against head lice?EUCTR2011-001892-38-GBPanin S.r.l.44
Completed
Not Applicable
Is Liceko® more effective than Nix® / Lyclear® against head lice?Head louse infestationInfections and InfestationsPediculosis due to Pediculus humanus capitisISRCTN45553737Panin S.R.L (Italy)44
Active, not recruiting
Phase 1
A randomised, controlled, assessor-blind, clinical investigation of the activity of mosquito® LäuseShampoo compared with Infectopedicul® permethrin 0.5% lotion in the treatment of head lice - Comparing mosquito LauseShampoo with Infectopedicul lotioInfestation by head lice (pediculosis capitis)MedDRA version: 9.1 Level: LLT Classification code 10019199 Term: Head pediculosisEUCTR2010-019804-21-GBWepa Apothekenbedarf GmbH & Co KG96